TickerFacts.

Bon Natural Life Ltd (BON): R&D Expense

Annual figures by period end, from SEC filings.

$754.2K
Year ended 2025-09-30
+21.1%
3-year compound annual growth
+29.7%
5-year compound annual growth
$1.62M2019-09-30: $522.9K2020-09-30: $205.4K2021-09-30: $249.1K2022-09-30: $424.6K2023-09-30: $298.5K2024-09-30: $1.62M2025-09-30: $754.2K$754.2K
2019-09-30 R&D Expense (USD) 2025-09-30
Period endedR&D ExpenseChange YoYSource filing
2025-09-30$754.2K-53.5%2026-01-23, From 2024-10-01
2024-09-30$1.62M+443.0%2026-01-23, From 2023-10-01
2023-09-30$298.5K-29.7%2026-01-23, From 2022-10-01
2022-09-30$424.6K+70.5%2025-04-16, From 2021-10-01
2021-09-30$249.1K+21.3%2024-10-11, From 2020-10-01
2020-09-30$205.4K-60.7%2024-10-11, From 2019-10-01
2019-09-30$522.9Kn/a2022-01-31, From 2018-10-01

R&D Expense at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Bon Natural Life Ltd (BON)2025-09-30$754.2K-53.5%
Cyanotech Corp (CYAN)2025-03-31$449.0K-34.8%
Leef Brands Inc. (LEEEF)2025-12-31$19.7K+3.8%
Mannatech Inc (MTEX)2025-12-31$800.0K+14.3%
Niagen Bioscience, Inc. (NAGE)2025-12-31$6.33M+5.2%
Natural Alternatives International Inc (NAII)2025-06-30$1.80M-5.3%
Cronos Group Inc. (CRON)2025-12-31$4.45M+5.2%
Adia Nutrition, Inc. (ADIA)2025-12-31$29.1Kn/a
Tilray Brands, Inc. (TLRY)2026-05-31$361.0K+27.1%

Compare BON, CYAN, LEEEF, MTEX side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗